rationalization of physicochemical and structural requirement of some substituted 5-(biphenyl-4-ylmethyl)pyrazole as angiotensin ii receptor antagonist: a qsar approach
نویسندگان
چکیده
a series of angiotensin ii (a ii) receptor antagonist of some substituted 5-(biphenyl-4-ylmethyl) pyrazole were subjected to qsar analysis using hansch and fujita-ban model, by using combination of thermodynamic, electronic, spatial descriptor and presence or absence of substituent respectively. several qsar model were obtained using stepwise regression analysis. two models from both the method were selected on the basis of the statistical value that shows good significance with aii antagonistic activity. the best qsar models further validated by leave one out cross validation method. the studies have help to ascertain the role of different substituent in explaining the observed antagonistic activity of this analogue. from fujita-ban model, it is predicted that butane and propane at position 1, cooh at position 4 are essential for activity. group like ch2cf3 at position 1 and cooh in place of tetrazole at r3 position contribute negative to the biological activity. in hansch model it is predicted that molar refractivity at the 1 and 3 position shows positive contribution to the biological activity. field effect at position 4 also shows positives contribution to the biological activity. hydrogen donar at position r3 and field effect at position 1 contributes negatively to the biological activity.
منابع مشابه
Rationalization of Physicochemical and Structural Requirement of Some Substituted 5-(Biphenyl-4-ylmethyl)Pyrazole as Angiotensin II Receptor Antagonist: A QSAR Approach
A series of angiotensin II (A II) receptor antagonist of some substituted 5-(biphenyl-4-ylmethyl) pyrazole were subjected to QSAR analysis using Hansch and Fujita-Ban model, by using combination of thermodynamic, electronic, spatial descriptor and presence or absence of substituent respectively. Several QSAR model were obtained using stepwise regression analysis. Two models from both the ...
متن کاملPhysicochemical properties analysis and dopamine D2 receptor (D2R) docking of zotepine as an atypical antipsychotic antagonist
The main purpose of the present investigation is the study of therapeutically effect of Zotepine in schizophrenia disease treatment. In first step, the molecular structure of the said compound is optimized using density functional theory (DFT) technique by B3LYP functional method at 6-311++G(d,p) level of theory. Then the electronic properties of the title molecule are calculated using frontier...
متن کاملDesign, Synthesis, and Biological Evaluation of AT1 Angiotensin II Receptor 2 Substituted phenyl- (phenyl-{1- [2-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]- 1H-benzoimidazol-5-ylamine
Synthesis of a series of novel substituted benzimidazole derivatives by the condensation of ophenylenediamine (OPDA,) with Mandlic acid and subsequent reactions of the benzimidazole with different amino substituted is reported with reaction biphenyl tetrazole. All the compounds synthesized were screened for their potential anti-hypertensive properties,
متن کاملsome properties of fuzzy hilbert spaces and norm of operators
in this thesis, at first we investigate the bounded inverse theorem on fuzzy normed linear spaces and study the set of all compact operators on these spaces. then we introduce the notions of fuzzy boundedness and investigate a new norm operators and the relationship between continuity and boundedness. and, we show that the space of all fuzzy bounded operators is complete. finally, we define...
15 صفحه اولFimasartan, a novel angiotensin II receptor antagonist.
Fimasartan (Kanarb®), an angiotensin II receptor antagonist with selectivity for the AT1 receptor subtype, is a pyrimidinone-related heterocyclic compound that was developed by Boryung Pharm. Co., Ltd. Among numerous synthetic derivatives, fimasartan was chosen as a new drug candidate through in vitro and in vivo screening studies. Pharmadynamic-pharmacokinetic properties and safety profiles we...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
iranian journal of pharmaceutical sciencesجلد ۶، شماره ۱، صفحات ۵۱-۵۸
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023